181 related articles for article (PubMed ID: 33410456)
1. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy.
Weiss L; Jung KM; Nalbandian A; Llewellyn K; Yu H; Ta L; Chang I; Migliore M; Squire E; Ahmed F; Piomelli D; Kimonis V
Hum Mol Genet; 2021 Feb; 29(24):3945-3953. PubMed ID: 33410456
[TBL] [Abstract][Full Text] [Related]
2. VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy.
Cheng C; Weiss L; Leinonen H; Shmara A; Yin HZ; Ton T; Do A; Lee J; Ta L; Mohanty E; Vargas J; Weiss J; Palczewski K; Kimonis V
J Transl Med; 2022 Jan; 20(1):21. PubMed ID: 34998409
[TBL] [Abstract][Full Text] [Related]
3. Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.
Llewellyn KJ; Nalbandian A; Jung KM; Nguyen C; Avanesian A; Mozaffar T; Piomelli D; Kimonis VE
Hum Mol Genet; 2014 Mar; 23(5):1333-44. PubMed ID: 24158850
[TBL] [Abstract][Full Text] [Related]
4. Targeted excision of VCP R155H mutation by Cre-LoxP technology as a promising therapeutic strategy for valosin-containing protein disease.
Nalbandian A; Llewellyn KJ; Nguyen C; Monuki ES; Kimonis VE
Hum Gene Ther Methods; 2015 Feb; 26(1):13-24. PubMed ID: 25545721
[TBL] [Abstract][Full Text] [Related]
5. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
[TBL] [Abstract][Full Text] [Related]
6. The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress.
Rodriguez-Ortiz CJ; Flores JC; Valenzuela JA; Rodriguez GJ; Zumkehr J; Tran DN; Kimonis VE; Kitazawa M
Am J Pathol; 2016 Jun; 186(6):1623-34. PubMed ID: 27106764
[TBL] [Abstract][Full Text] [Related]
7. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
[TBL] [Abstract][Full Text] [Related]
8. A Fine Balance of Dietary Lipids Improves Pathology of a Murine Model of VCP-Associated Multisystem Proteinopathy.
Llewellyn KJ; Walker N; Nguyen C; Tan B; BenMohamed L; Kimonis VE; Nalbandian A
PLoS One; 2015; 10(7):e0131995. PubMed ID: 26134519
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
Weihl CC; Miller SE; Hanson PI; Pestronk A
Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
[TBL] [Abstract][Full Text] [Related]
10. Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo.
Kustermann M; Manta L; Paone C; Kustermann J; Lausser L; Wiesner C; Eichinger L; Clemen CS; Schröder R; Kestler HA; Sandri M; Rottbauer W; Just S
Autophagy; 2018; 14(11):1911-1927. PubMed ID: 30010465
[TBL] [Abstract][Full Text] [Related]
11. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.
Nalbandian A; Llewellyn KJ; Badadani M; Yin HZ; Nguyen C; Katheria V; Watts G; Mukherjee J; Vesa J; Caiozzo V; Mozaffar T; Weiss JH; Kimonis VE
Muscle Nerve; 2013 Feb; 47(2):260-70. PubMed ID: 23169451
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.
Nalbandian A; Llewellyn KJ; Nguyen C; Yazdi PG; Kimonis VE
PLoS One; 2015; 10(4):e0122888. PubMed ID: 25884947
[TBL] [Abstract][Full Text] [Related]
13. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.
Vesa J; Su H; Watts GD; Krause S; Walter MC; Martin B; Smith C; Wallace DC; Kimonis VE
Neuromuscul Disord; 2009 Nov; 19(11):766-72. PubMed ID: 19828315
[TBL] [Abstract][Full Text] [Related]
14. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
[TBL] [Abstract][Full Text] [Related]
15. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-Mediated Constitutive Loss of VCP (Valosin-Containing Protein) Impairs Proteostasis and Leads to Defective Striated Muscle Structure and Function In Vivo.
Voisard P; Diofano F; Glazier AA; Rottbauer W; Just S
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743185
[TBL] [Abstract][Full Text] [Related]
17. Pathological consequences of VCP mutations on human striated muscle.
Hübbers CU; Clemen CS; Kesper K; Böddrich A; Hofmann A; Kämäräinen O; Tolksdorf K; Stumpf M; Reichelt J; Roth U; Krause S; Watts G; Kimonis V; Wattjes MP; Reimann J; Thal DR; Biermann K; Evert BO; Lochmüller H; Wanker EE; Schoser BG; Noegel AA; Schröder R
Brain; 2007 Feb; 130(Pt 2):381-93. PubMed ID: 16984901
[TBL] [Abstract][Full Text] [Related]
18. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.
Arhzaouy K; Papadopoulos C; Schulze N; Pittman SK; Meyer H; Weihl CC
Autophagy; 2019 Jun; 15(6):1082-1099. PubMed ID: 30654731
[TBL] [Abstract][Full Text] [Related]
19. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease.
Nalbandian A; Nguyen C; Katheria V; Llewellyn KJ; Badadani M; Caiozzo V; Kimonis VE
PLoS One; 2013; 8(10):e76187. PubMed ID: 24130765
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy.
Ching JK; Weihl CC
Autophagy; 2013 May; 9(5):799-800. PubMed ID: 23439279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
